HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Editorial: 'Stink!' Documentary On Fragrance Ills Presents Nothing New, Effectively

This article was originally published in The Rose Sheet

Executive Summary

Set to launch to video-on-demand platforms Feb. 16, critically hailed documentary "Stink!" casts the fragrance industry as its central villain, pressing for full transparency in fragrance ingredient use, among other reforms to US chemicals regulation. Director/producer Jon Whelan's argument has holes and underrepresents industry, but his message is reaching a wide audience of receptive ears.

You may also be interested in...



‘Toxic Beauty’ Documentary And The Growing Conversation Around ‘Clean’ Alternatives

Dermatologists and industry advocates are concerned about the public’s lack of trust in science and potentially misplaced faith in “clean” beauty, which “Toxic Beauty” screenings in the US, Canada and UK likely are only reinforcing.

Unilever Commits To Personal-Care Fragrance Disclosure; Who’s Next?

Unilever’s announcement that it will disclose fragrance ingredients in personal-care products is a potential game-changer for the industry, representing a heretofore unseen level of transparency from a leading multinational.

IFRA’s New Prez On Fragrance Transparency, The Science/Society ‘Interface’

Four months into her presidency, the International Fragrance Association’s new head discusses key issues and priorities, including ingredient disclosure in a sector that jealously guards its trade secrets.

Related Content

Topics

UsernamePublicRestriction

Register

SC066183

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel